The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers who have significant controls over the individuals in focus are always inapplicable. The offspring entities and appointments are those entities that the individuals in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Inapplicable
parent relation
Individuals in focus

Mirzo, Ilhom

    Related profiles found in government register
  • Mirzo, Ilhom
    Tajik pharmaceutical business born in December 1980

    Resident in Tajikistan

    Registered addresses and corresponding companies
    • Astra House, Arklow Road, London, England, United Kingdom, SE14 6EB, United Kingdom

      IIF 1
    • C/o Spey Medical Ltd (menzies Llp), Lynton House, 7-12 Tavistock Square, London, WC1H 9LT, United Kingdom

      IIF 2
    • Unit 18, 53 Norman Road, Greenwich Centre Business Park, London, SE10 9QF, England

      IIF 3
  • Mirzo, Ilhom
    born in December 1980

    Resident in Tajikistan

    Registered addresses and corresponding companies
    • 322-328, Kahhorov Street, Dushanbe, Tajikistan, Tajikistan

      IIF 4
  • Ilhom Mirzo
    Tajik born in December 1980

    Resident in Tajikistan

    Registered addresses and corresponding companies
    • Unit 18, 53 Norman Road, Greenwich Centre Business Park, London, SE109QF, United Kingdom

      IIF 5
  • Mr Ilhom Mirzo
    Tajik born in December 1980

    Resident in Tajikistan

    Registered addresses and corresponding companies
    • Lspechak-1, 5th Lane, House Number 26, Dushanbe City, Tajikistan

      IIF 6
    • 322-328, Kahhorov Street, Dushanbe, Tajikistan, Tajikistan

      IIF 7
  • Mr Ilkhomzhon Mirzoev
    Tajik born in December 1980

    Resident in Tajikistan

    Registered addresses and corresponding companies
    • C/o Spey Medical Ltd (menzies Llp), Lynton House, 7-12 Tavistock Square, London, WC1H 9LT

      IIF 8
  • Mr. Mirzoev Ilkhomzhon
    Tajik born in December 1980

    Resident in Republic Of Tajikistan

    Registered addresses and corresponding companies
    • House 322.328, Kaharova Street, Dushanbe City, Republic Of Tajikistan, Republic Of Tajikistan

      IIF 9
  • Mr Ilkhomzhon Mirzoev
    Tajik born in December 1980

    Resident in Republic Of Tajikistan

    Registered addresses and corresponding companies
    • Kahorov Street 322, Apt. 328, Dushanbe, Firdavsi District, Republic Of Tajikistan

      IIF 10
child relation
Offspring entities and appointments
Active 7
  • 1
    C/o Shipra Berera Flat No 13, 49 Crispin Street, London, United Kingdom
    Corporate (3 parents)
    Person with significant control
    2023-05-04 ~ now
    IIF 5 - Right to surplus assets - More than 25% but not more than 50%OE
    IIF 5 - Right to surplus assets - More than 25% but not more than 50% as a member of a firmOE
    IIF 5 - Right to appoint or remove membersOE
    IIF 5 - Right to appoint or remove members as a member of a firmOE
  • 2
    C/o Shipra Berera, Flat No. 13, 49 Crispin Street, London, United Kingdom
    Corporate (3 parents)
    Person with significant control
    2018-10-26 ~ now
    IIF 6 - Has significant influence or controlOE
  • 3
    Unit 18, 53 Norman Road, Greenwich Centre Business Park, London, England
    Corporate (5 parents, 4 offsprings)
    Equity (Company account)
    -7,364 GBP2023-10-31
    Officer
    2018-04-09 ~ now
    IIF 1 - director → ME
  • 4
    NEOPHARM MARKETING LLP - 2011-12-02
    Unit 18, 53 Norman Road, Greenwich Centre Business Park, London, England
    Corporate (3 parents, 2 offsprings)
    Officer
    2019-11-01 ~ now
    IIF 4 - llp-designated-member → ME
    Person with significant control
    2019-11-01 ~ now
    IIF 7 - Ownership of voting rights - More than 25% but not more than 50%OE
    IIF 7 - Right to surplus assets - More than 25% but not more than 50%OE
    IIF 7 - Right to appoint or remove membersOE
  • 5
    ABSTRAGAN LIMITED - 2021-04-27
    Unit 18, 53 Norman Road, Greenwich Centre Business Park, London, England
    Corporate (2 parents, 5 offsprings)
    Equity (Company account)
    100 GBP2023-09-30
    Officer
    2015-09-22 ~ now
    IIF 3 - director → ME
  • 6
    4th Floor 95 Gresham Street, London, United Kingdom
    Corporate (4 parents)
    Equity (Company account)
    11,591 GBP2023-12-31
    Officer
    2013-11-12 ~ now
    IIF 2 - director → ME
  • 7
    VEGAPHARM INTERNATIONAL LLP - 2010-08-27
    Unit 18, 53 Norman Road, Greenwich Centre Business Park, London, England
    Corporate (3 parents)
    Person with significant control
    2016-04-06 ~ now
    IIF 10 - Has significant influence or controlOE
Ceased 2
  • 1
    ABSTRAGAN LIMITED - 2021-04-27
    Unit 18, 53 Norman Road, Greenwich Centre Business Park, London, England
    Corporate (2 parents, 5 offsprings)
    Equity (Company account)
    100 GBP2023-09-30
    Person with significant control
    2016-04-06 ~ 2018-06-26
    IIF 9 - Ownership of shares – More than 25% but not more than 50% OE
    IIF 9 - Ownership of voting rights - More than 25% but not more than 50% OE
    IIF 9 - Has significant influence or control OE
  • 2
    4th Floor 95 Gresham Street, London, United Kingdom
    Corporate (4 parents)
    Equity (Company account)
    11,591 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ 2016-07-21
    IIF 8 - Ownership of shares – More than 25% but not more than 50% OE
    IIF 8 - Ownership of voting rights - More than 25% but not more than 50% OE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.